BI Asset Management Fondsmaeglerselskab A/S
Position in LLY — ELI LILLY & Co
CIK 1778131
KOBENHAVN, G7
Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$229,135,528
+$101,919,380 QoQ
Shares Held
191,037
+38.1% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
1.83%
of 13F equity value
Holder Rank
#246
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $648,972,761 across 12 Drug Manufacturers - General names. LLY ranks #1 (35.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
191,037 | $229,135,528 | |
| 2 | JNJ |
Johnson & Johnson
|
488,378 | $124,033,360 | |
| 3 | ABBV |
AbbVie Inc.
|
241,796 | $60,845,545 | |
| 4 | MRK |
Merck & Co., Inc.
|
468,644 | $60,220,754 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,033,357 | $59,542,030 | |
| 6 | GSK |
GSK plc
|
911,826 | $47,797,918 | |
| 7 | AMGN |
Amgen Inc
|
63,977 | $23,167,351 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
181,413 | $22,919,718 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $229,135,528 | 191,037 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $127,216,148 | 138,313 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $185,407,034 | 172,523 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $95,844,245 | 125,615 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $116,256,765 | 149,137 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $90,996,286 | 110,177 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $98,096,496 | 127,068 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $88,289,236 | 99,656 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $51,281,628 | 56,641 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $41,395,251 | 53,210 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $22,262,880 | 38,192 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $57,109,272 | 106,323 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $45,618,153 | 97,271 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $30,584,641 | 89,059 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $49,182,066 | 134,436 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $37,163,262 | 114,932 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $36,299,169 | 111,955 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $41,668,553 | 145,506 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $37,781,095 | 136,779 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $33,997,852 | 147,145 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $38,860,949 | 169,314 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $37,966,681 | 203,226 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $33,563,534 | 198,789 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $32,918,463 | 222,392 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $28,304,960 | 172,402 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $26,140,674 | 188,442 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||